Covid-19 New

More Info

Open access Aims and Scope Instructions Editorial Guidelines Licensing Copyright

Author's satisfaction with

  • Friendly and hassle-free publication process
  • Less production time of articles
  • Constructive peer-review
  • Enhancing journal reputation
  • Regular feedback system
  • Quick response to authors' queries

Read More

Recently Viewed

Prevalence of Musculoskeletal Disorders among Garment Worker The motivational factors and adverse events experienced by h Novel European Asiatic Clinical, Laboratory, Molecular and P Non-variant phenomena in heterogeneous systems. New type of Evaluation of In vitro and Ex vivo Models for Studying the E

Read More

Most Viewed

Evaluation of Biostimulants Based on Recovered Protein Hydro Feasibility study of magnetic sensing for detecting single-n Physical activity can change the physiological and psycholog Pediatric Dysgerminoma: Unveiling a Rare Ovarian Tumor Prospective Coronavirus Liver Effects: Available Knowledge

Read More

Open Journals

Clinical Images

For Authors Guide For Authors Benefits For Authors Article Processing Charge How To Write a Scientific Paper How To Write a Review Article Short Communication
For Reviewers Benefits For Reviewers How To Review Thanks To Reviewers
For Editors Benefits For Editors Thanks To Editors

Abstract

Review Article

Glycosaminoglycans as Novel Targets for in vivo Contrast-Enhanced Magnetic Resonance Imaging of Atherosclerosis

Yavuz O Uca* and Matthias Taupitz

Published: 20 April, 2020 | Volume 5 - Issue 1 | Pages: 080-088

Atherosclerosis is an important promoter of cardiovascular disease potentiating myocardial infarction or stroke. Current demand in biomedical imaging necessitates noninvasive characterization of arterial changes responsible for transition of stable plaque into rupture-prone vulnerable plaque. in vivo contrast enhanced magnetic resonance (MR) imaging (MRI) allows quantitative and functional monitoring of pathomorphological changes through signal differences induced by the contrast agent uptake in the diseased vessel wall, therefore it is the ideal modality toward this goal. However, studies have so far focused on the cellular targets of persisting inflammation, leaving extracellular matrix (ECM) far behind. In this review, we portray ECM remodeling during atherosclerotic plaque progression by summarizing the state of the-art in MRI and current imaging targets. Finally, we aim to discuss glycosaminoglycans (GAGs) and their functional interactions, which might offer potential toward development of novel imaging probes for in vivo contrast-enhanced MRI of atherosclerosis.

Read Full Article HTML DOI: 10.29328/journal.jccm.1001091 Cite this Article Read Full Article PDF

References

  1. Ross R. Atherosclerosis — An Inflammatory Disease. N Engl J Med. 1999; 340: 115–126. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/9887164
  2. Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, et al. Heart disease and stroke statistics-2019 update: a report From the American Heart Association. Circulation. 2019; 139 :526–528. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/30700139
  3. Nichols M, Townsend N, Scarborough P, Rayner M. Cardiovascular disease in Europe 2014: epidemiological update. Eur Heart J. 2014; 35: 2950–2959. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/25139896
  4. Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, et al. Forecasting the Future of Cardiovascular Disease in the United States: A Policy Statement From the American Heart Association. Circulation. 2011; 123: 933–944. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21262990
  5. Nojiri S, Daida H. Atherosclerotic Cardiovascular Risk in Japan. Jpn Clin Med [Internet]. 2017; 8. PubMed: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5480958/
  6. Pozo E, Agudo-Quilez P, Rojas-González A, Alvarado T, Olivera MJ, et al. Noninvasive diagnosis of vulnerable coronary plaque. World J Cardiol. 2016; 8: 520–533. PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039354/
  7. Tarkin JM, Dweck MR, Evans NR, Takx RA, Brown AJ, et al. Imaging atherosclerosis. Circ Res. 2016; 118: 750–769. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/26892971
  8. Skinner MP, Yuan C, Mitsumori L, Hayes CE, M.p.s EWR, Nelson JA, et al. Serial magnetic resonance imaging of experimental atherosclerosis detects lesion fine structure, progression and complications in vivo. Nat Med. 1995; 1: 69–73. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/7584956
  9. Toussaint J-F, LaMuraglia GM, Southern JF, Fuster V, Kantor HL. Magnetic Resonance Images Lipid, Fibrous, Calcified, Hemorrhagic, and Thrombotic Components of Human Atherosclerosis in vivo. Circulation. 1996; 94: 932–8.
  10. Botnar RM, Stuber M, Kissinger KV, Kim WY, Spuentrup E, et al. Noninvasive Coronary Vessel Wall and Plaque Imaging With Magnetic Resonance Imaging. Circulation. 2000; 102: 2582–2587. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/11085960
  11. Fayad ZA, Fuster V. Clinical Imaging of the High-Risk or Vulnerable Atherosclerotic Plaque. Circ Res. 2001; 89: 305–316. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/11509446
  12. Tang TY, Muller KH, Graves MJ, Li ZY, Walsh SR, et al. Iron Oxide Particles for Atheroma Imaging. Arterioscler Thromb Vasc Biol. 2009; 29:1001–1008. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/19229073
  13. Falk E, Shah PK, Fuster V. Coronary Plaque Disruption. Circulation. 1995; 92: 657–671. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/7634481
  14. Virmani R, Kolodgie FD, Burke AP, Finn AV, Gold HK, N T, et al. Atherosclerotic Plaque Progression and Vulnerability to Rupture.
  15. Hansson GK. Inflammation, Atherosclerosis, and Coronary Artery Disease. N Engl J Med. 2005; 352: 1685–1695. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/15843671
  16. Libby P, DiCarli M, Weissleder R. The Vascular Biology of Atherosclerosis and Imaging Targets. J Nucl Med. 2010; 51(Supplement 1): 335-375. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/20395349
  17. Rudd JHF, Hyafil F, Fayad ZA. Inflammation Imaging in Atherosclerosis. Arterioscler Thromb Vasc Biol. 2009; 29: 1009–1016.
  18. Reimann C, Brangsch J, Colletini F, Walter T, Hamm B, Botnar RM, et al. Molecular imaging of the extracellular matrix in the context of atherosclerosis. Adv Drug Deliv Rev. 2017; 113:49–60. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/27639968
  19. Virmani R, Burke AP, Farb A, Kolodgie FD. Pathology of the Vulnerable Plaque. J Am Coll Cardiol. 2006; 47(8 Supplement): C13–18. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/16631505
  20. Järveläinen H, Sainio A, Koulu M, Wight TN, Penttinen R. Extracellular Matrix Molecules: Potential Targets in Pharmacotherapy. Pharmacol Rev. 2009; 61:198–223. PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2830117/s
  21. Lutolf MP, Hubbell JA. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol. 2005; 23: 47–55. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/15637621
  22. Grobner T. Gadolinium – a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant. 2006; 21: 1104–1108. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/16431890
  23. George S j., Webb S m., Abraham J l., Cramer S p. Synchrotron X-ray analyses demonstrate phosphate-bound gadolinium in skin in nephrogenic systemic fibrosis. Br J Dermatol. 2010; 163: 1077–1081. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/20560953
  24. Laurent S, Vander Elst L, Henoumont C, Muller RN. How to measure the transmetallation of a gadolinium complex. Contrast Media Mol Imaging. 2010; 5: 305–308. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/20803503
  25. Taupitz M, Stolzenburg N, Ebert M, Schnorr J, Hauptmann R, Kratz H, et al. Gadolinium-containing magnetic resonance contrast media: investigation on the possible transchelation of Gd 3+ to the glycosaminoglycan heparin: GdCM, Glycosaminoglycans and Transchelation. Contrast Media Mol Imaging. 2013; 8:108–116. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/23281283
  26. Narula J, Virmani R, Iskandrian AE. Strategic targeting of atherosclerotic lesions. J Nucl Cardiol. 1999; 6: 81–90. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/10070844
  27. Chatzizisis YS, Coskun AU, Jonas M, Edelman ER, Feldman CL, et al. Role of Endothelial Shear Stress in the Natural History of Coronary Atherosclerosis and Vascular Remodeling: Molecular, Cellular, and Vascular Behavior. J Am Coll Cardiol. 2007; 49: 2379–2393. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/17599600
  28. Gimbrone MA, Topper JN, Nagel T, Anderson KR, Garcia-Cardeña G. Endothelial Dysfunction, Hemodynamic Forces, and Atherogenesisa. Ann N Y Acad Sci. 2000; 902: 230–240. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/10865843
  29. Navab M, Ananthramaiah GM, Reddy ST, Van Lenten BJ, Ansell BJ, et al. The Pathogenesis of Atherosclerosis-The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL. J Lipid Res. 2004; 45: 993–1007. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/15060092
  30. Blankenberg S, Barbaux S, Tiret L. Adhesion molecules and atherosclerosis. Atherosclerosis. 2003; 170: 191–203. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/14612198
  31. Winter PM, Morawski AM, Caruthers SD, Fuhrhop RW, Zhang H, et al. Molecular Imaging of Angiogenesis in Early-Stage Atherosclerosis With αvβ3-Integrin–Targeted Nanoparticles. Circulation. 2003; 108: 2270–2274. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/14557370
  32. Galkina E, Ley K. Vascular Adhesion Molecules in Atherosclerosis. Arterioscler Thromb Vasc Biol. 2007; 27: 2292–2301. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/17673705
  33. Kelly KA, Allport JR, Tsourkas A, Shinde-Patil VR, Josephson L, et al. Detection of Vascular Adhesion Molecule-1 Expression Using a Novel Multimodal Nanoparticle. Circ Res. 2005; 96: 327–336. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/15653572
  34. Nahrendorf M, Jaffer FA, Kelly KA, Sosnovik DE, Aikawa E, et al. Noninvasive Vascular Cell Adhesion Molecule-1 Imaging Identifies Inflammatory Activation of Cells in Atherosclerosis. Circulation. 2006; 114: 1504–1511. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/17000904
  35. Briley-Saebo KC, Shaw PX, Mulder WJM, Choi S-H, Vucic E, et al. Targeted Molecular Probes for Imaging Atherosclerotic Lesions With Magnetic Resonance Using Antibodies That Recognize Oxidation-Specific Epitopes. Circulation. 2008; 117: 3206–3215. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/18541740
  36. McAteer MA, Schneider JE, Ali ZA, Warrick 1 Nicholas, Bursill CA, et al. Magnetic Resonance Imaging of Endothelial Adhesion Molecules in Mouse Atherosclerosis Using Dual-Targeted Microparticles of Iron Oxide. Arterioscler Thromb Vasc Biol. 2008 Jan;28(1):77–83. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/17962629
  37. Kwon HM, Sangiorgi G, Ritman EL, McKenna C, Holmes DR, et al. Enhanced coronary vasa vasorum neovascularization in experimental hypercholesterolemia. J Clin Invest. 1998; 101: 1551–1556. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/9541483
  38. Libby P. Inflammation in atherosclerosis. Nature. 2002; 420: 868–874.
  39. Amirbekian V, Lipinski MJ, Briley-Saebo KC, Amirbekian S, Aguinaldo JGS, et al. Detecting and assessing macrophages in vivo to evaluate atherosclerosis noninvasively using molecular MRI. Proc Natl Acad Sci. 2007; 104: 961–966. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/17215360
  40. Ruehm SG, Corot C, Vogt P, Kolb S, Debatin JF. Magnetic Resonance Imaging of Atherosclerotic Plaque With Ultrasmall Superparamagnetic Particles of Iron Oxide in Hyperlipidemic Rabbits. Circulation. 2001; 103: 415–422. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/11157694
  41. Schmitz SA, Taupitz M, Wagner S, Wolf K-J, Beyersdorff D, et al. Magnetic resonance imaging of atherosclerotic plaques using superparamagnetic iron oxide particles. J Magn Reson Imaging. 2001; 14: 355–361. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/11599058
  42. Kooi ME, Cappendijk VC, Cleutjens KBJM, Kessels AGH, Kitslaar PJEHM, et al. Accumulation of Ultrasmall Superparamagnetic Particles of Iron Oxide in Human Atherosclerotic Plaques Can Be Detected by in vivo Magnetic Resonance Imaging. Circulation. 2003; 107: 2453–2458. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/12719280
  43. Chen J, Tung CH, Mahmood U, Ntziachristos V, Gyurko R, et al. in vivo Imaging of Proteolytic Activity in Atherosclerosis. Circulation. 2002; 105: 2766–2771. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/12057992
  44. Deguchi J, Aikawa M, Tung C-H, Aikawa E, Kim D-E, et al. Inflammation in Atherosclerosis: Visualizing Matrix Metalloproteinase Action in Macrophages in vivo. Circulation. 2006 Jul 4;114(1):55–62. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/16801460
  45. Shipley JM, Wesselschmidt RL, Kobayashi DK, Ley TJ, Shapiro SD. Metalloelastase is required for macrophage-mediated proteolysis and matrix invasion in mice. Proc Natl Acad Sci. 1996; 93: 3942–3946. PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC39464/
  46. Hyafil F, Vucic E, Cornily J-C, Sharma R, Amirbekian V, et al. Monitoring of arterial wall remodelling in atherosclerotic rabbits with a magnetic resonance imaging contrast agent binding to matrix metalloproteinases. Eur Heart J. 2011; 32: 1561–1571. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21118852
  47. Helske S, Syväranta S, Lindstedt KA, Lappalainen J, Öörni K, et al. Increased Expression of Elastolytic Cathepsins S, K, and V and Their Inhibitor Cystatin C in Stenotic Aortic Valves. Arterioscler Thromb Vasc Biol. 2006; 26: 1791–1798. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/16728655
  48. Majmudar MD, Nahrendorf M. Cardiovascular Molecular Imaging: The Road Ahead. J Nucl Med. 2012; 53: 673–676. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/22492729
  49. Lairez O, Fayad ZA. Imaging of atherosclerosis: Can molecular imaging do more? Arch Cardiovasc Dis. 2013; 106: 551–553.
  50. Carlier S, Kakadiaris IA, Dib N, Vavuranakis M, O’Malley SM, et al. Vasa vasorum imaging: A new window to the clinical detection of vulnerable atherosclerotic plaques. Curr Atheroscler Rep. 2005; 7: 164–169. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/15727733
  51. Vakonakis I, Campbell ID. Extracellular matrix: from atomic resolution to ultrastructure. Curr Opin Cell Biol. 2007; 19: 578–583. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/17942296
  52. Aumailley M, Gayraud B. Structure and biological activity of the extracellular matrix. J Mol Med. 1998; 76: 253–265. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/9535559
  53. Katsuda S, Kaji T. Atherosclerosis and Extracellular Matrix. J Atheroscler Thromb. 2003; 10: 267–274. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/14718743
  54. Wight TN, Lara S, Riessen R, Le Baron R, Isner J. Selective deposits of versican in the extracellular matrix of restenotic lesions from human peripheral arteries. Am J Pathol. 1997; 151: 963-973. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/9327730
  55. Wight TN, Merrilees MJ. Proteoglycans in Atherosclerosis and Restenosis: Key Roles for Versican. Circ Res. 2004; 94: 1158–1167. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/15142969
  56. Matter CM, Schuler PK, Alessi P, Meier P, Ricci R, Zhang D, et al. Molecular Imaging of Atherosclerotic Plaques Using a Human Antibody Against the Extra-Domain B of Fibronectin. Circ Res. 2004; 95: 1225–1233.
  57. Ye F, Jeong E-K, Jia Z, Yang T, Parker D, et al. A Peptide Targeted Contrast Agent Specific to Fibrin-Fibronectin Complexes for Cancer Molecular Imaging with MRI. Bioconjug Chem. 2008; 19: 2300–2303. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/19053180
  58. Mayne R. Collagenous proteins of blood vessels. Arterioscler Thromb Vasc Biol. 1986; 6: 585–593.
  59. Brodsky B, Persikov AV. Molecular Structure of the Collagen Triple Helix. Adv Protein Chem. 2005; 70: 301–339. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/15837519
  60. Caravan P, Das B, Dumas S, Epstein FH, Helm PA, et al. Collagen-Targeted MRI Contrast Agent for Molecular Imaging of Fibrosis. Angew Chem. 2007; 119: 8319–8321. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/17893943
  61. Helm PA, Caravan P, French BA, Jacques V, Shen L, Xu Y, et al. Postinfarction myocardial scarring in mice: molecular MR imaging with use of a collagen-targeting contrast agent. Radiology. 2008; 247: 788–796. PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410958/
  62. Jimi S, Sakata N, Matunaga A, Takebayashi S. Low density lipoproteins bind more to type I and III collagens by negative charge-dependent mechanisms than to type IV and V collagens. Atherosclerosis. 1994; 107: 109–116. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/7945553
  63. Khalil MF. Molecular Interactions Leading to Lipoprotein Retention and the Initiation of Atherosclerosis. Arterioscler Thromb Vasc Biol. 2004; 24: 2211–2218. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/15472124
  64. Adiguzel E, Ahmad PJ, Franco C, Bendeck MP. Collagens in the progression and complications of atherosclerosis. Vasc Med. 2009; 14: 73–89. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/19144782
  65. Chen W, Cormode DP, Vengrenyuk Y, Herranz B, Feig JE, et al. Collagen-Specific Peptide Conjugated HDL Nanoparticles as MRI Contrast Agent to Evaluate Compositional Changes in Atherosclerotic Plaque Regression. JACC Cardiovasc Imaging. 2013; 6: 373–384. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/23433925
  66. Spuentrup E, Ruhl KM, Botnar RM, Wiethoff AJ, Buhl A, et al. Molecular Magnetic Resonance Imaging of Myocardial Perfusion With EP-3600, a Collagen-Specific Contrast Agent: Initial Feasibility Study in a Swine Model. Circulation. 2009; 119: 1768–1775. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/19307474
  67. Li DY, Brooke B, Davis EC, Mecham RP, Sorensen LK, et al. Elastin is an essential determinant of arterial morphogenesis. Nature. 1998; 393: 276–280. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/9607766
  68. Karnik SK, Brooke BS, Bayes-Genis A, Sorensen L, Wythe JD, et al. A critical role for elastin signaling in vascular morphogenesis and disease. Development. 2003; 130: 411–423. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/12466207
  69. Kwon GP, Schroeder JL, Amar MJ, Remaley AT, Balaban RS. Contribution of Macromolecular Structure to the Retention of Low-Density Lipoprotein at Arterial Branch Points. Circulation. 2008; 117: 2919–2927. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/18506002
  70. Robert L, Robert AM, Jacotot B. Elastin–elastase–atherosclerosis revisited. Atherosclerosis. 1998; 140: 281–295. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/9862271
  71. Krettek A, Sukhova GK, Libby P. Elastogenesis in Human Arterial Disease: A Role for Macrophages in Disordered Elastin Synthesis. Arterioscler Thromb Vasc Biol. 2003; 23: 582–587. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/12615674
  72. Choudhury Robin P, Valentin F, Badimon Juan J, Fisher Edward A, Fayad Zahi A. MRI and Characterization of Atherosclerotic Plaque. Arterioscler Thromb Vasc Biol. 2002; 22: 1065–1074. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/12117718
  73. Makowski MR, Wiethoff AJ, Blume U, Cuello F, Warley A, et al. Assessment of atherosclerotic plaque burden with an elastin-specific magnetic resonance contrast agent. Nat Med. 2011; 17: 383–388. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21336283
  74. Fuster V, Stein B, Ambrose JA, Badimon L, Badimon JJ, et al. Atherosclerotic plaque rupture and thrombosis. Evolving concepts. Circulation. 1990; 82(3 Suppl): II47-1159. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/2203564
  75. La Corte ALC, Philippou H, Ariëns RAS. Role of Fibrin Structure in Thrombosis and Vascular Disease. Adv Protein Chem Struct Biol. 2011; 83: 75–127. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21570666
  76. Tavora F, Cresswell N, Li L, Ripple M, Burke A. Immunolocalisation of fibrin in coronary atherosclerosis: implications for necrotic core development. Pathology (Phila). 2010; 42: 15‑ PubMed: https://www.ncbi.nlm.nih.gov/pubmed/20025475
  77. Botnar RM, Perez AS, Witte S, Wiethoff AJ, Laredo J, et al. in vivo Molecular Imaging of Acute and Subacute Thrombosis Using a Fibrin-Binding Magnetic Resonance Imaging Contrast Agent. Circulation. 2004; 109: 2023–2029. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/15066940
  78. Makowski MR, Forbes SC, Blume U, Warley A, Jansen CHP, et al. in vivo assessment of intraplaque and endothelial fibrin in ApoE−/− mice by molecular MRI. Atherosclerosis. 2012; 222: 43–49.
  79. Flacke S, Fischer S, Scott MJ, Fuhrhop RJ, Allen JS, et al. Novel MRI Contrast Agent for Molecular Imaging of Fibrin: Implications for Detecting Vulnerable Plaques. Circulation. 2001; 104: 1280–1285. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/11551880
  80. Sirol M, Aguinaldo JGS, Graham PB, Weisskoff R, Lauffer R, et al. Fibrin-targeted contrast agent for improvement of in vivo acute thrombus detection with magnetic resonance imaging. Atherosclerosis. 2005; 182: 79–85. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/16115477
  81. Jackson RL, Busch SJ, Cardin AD. Glycosaminoglucans : molecular properties, protein interactions, and role in physiological processes. Physiol Rev. 1991; 71: 481–539. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/2006221
  82. Salisbury BG, Wagner WD. Isolation and preliminary characterization of proteoglycans dissociatively extracted from human aorta. J Biol Chem. 1981; 256: 8050–8057. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/7263639
  83. Berenson GS, Radhakrishnamurthy B, Srinivasan SR, Vijayagopal P, Dalferes ER. Proteoglycans and Potential Mechanisms Related to Atherosclerosisa. Ann N Y Acad Sci. 1985; 454: 69–78. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/3865616
  84. Taylor KR, Gallo RL. Glycosaminoglycans and their proteoglycans: host-associated molecular patterns for initiation and modulation of inflammation. FASEB J. 2006; 20: 9–22. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/16394262
  85. Lindahl U, Hook M. Glycosaminoglycans and their binding to biological macromolecules. Annu Rev Biochem. 1978; 47: 385–417. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/354500
  86. Turnbull J, Powell A, Guimond S. Heparan sulfate: decoding a dynamic multifunctional cell regulator. Trends Cell Biol. 2001; 11: 75–82. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/11166215
  87. Nugent MA. Heparin sequencing brings structure to the function of complex oligosaccharides. Proc Natl Acad Sci. 2000; 97: 10301–10303. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/10984527
  88. Evanko SP, Raines EW, Ross R, Gold LI, Wight TN. Proteoglycan distribution in lesions of atherosclerosis depends on lesion severity, structural characteristics, and the proximity of platelet-derived growth factor and transforming growth factor-beta. Am J Pathol. 1998; 152: 533–546. PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1857967/
  89. Stevens RL, Colombo M, Gonzales JJ, Hollander W, Schmid K. The glycosaminoglycans of the human artery and their changes in atherosclerosis. J Clin Invest. 1976; 58: 470–481. PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC333202/
  90. Ballinger ML, Nigro J, Frontanilla KV, Dart AM, Little PJ. Regulation of glycosaminoglycan structure and atherogenesis. Cell Mol Life Sci CMLS. 2004; 61: 1296–1306. pubMed: https://www.ncbi.nlm.nih.gov/pubmed/15170508
  91. Kolodgie FD, Burke AP, Farb A, Weber DK, Kutys R, et al. Differential Accumulation of Proteoglycans and Hyaluronan in Culprit Lesions: Insights Into Plaque Erosion. Arterioscler Thromb Vasc Biol. 2002; 22: 1642–1648. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/12377743
  92. O'Brien KD, Olin KL, Alpers CE, Chiu W, Ferguson M, et al. Comparison of Apolipoprotein and Proteoglycan Deposits in Human Coronary Atherosclerotic Plaques: Colocalization of Biglycan With Apolipoproteins. Circulation. 1998; 98: 519–527. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/9714108
  93. Merrilees MJ, Beaumont B, Scott LJ. Comparison of deposits of versican, biglycan and decorin in saphenous vein and internal thoracic, radial and coronary arteries: correlation to patency. Coron Artery Dis. 2001; 12:7–16. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/11211169
  94. Radhakrishnamurthy B, Srinivasan SR, Vijayagopal P, Berenson GS. Arterial wall proteoglycans‑biological properties related to pathogenesis of atherosclerosis. Eur Heart J. 1990; 11: 148‑ PubMed: https://www.ncbi.nlm.nih.gov/pubmed/2226523
  95. Reitsma S, Slaaf DW, Vink H, van Zandvoort MAMJ, oude Egbrink MGA. The endothelial glycocalyx: composition, functions, and visualization. Pflüg Arch - Eur J Physiol. 2007; 454: 345–59. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/17256154
  96. Tarbell JM, Cancel LM. The glycocalyx and its significance in human medicine. J Intern Med. 2016; 280:97–113. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/26749537
  97. Selleck SB. Proteoglycans and pattern formation: sugar biochemistry meets developmental genetics. Trends Genet. 2000; 16: 206–212. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/10782114
  98. Hileman RE, Fromm JR, Weiler JM, Linhardt RJ. Glycosaminoglycan-protein interactions: definition of consensus sites in glycosaminoglycan binding proteins. Bioessays. 1998; 20: 156–167. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/9631661
  99. Wight TN. The extracellular matrix and atherosclerosis. Curr Opin Lipidol. 1995; 6: 326.
  100. Scott JE. Structure and function in extracellular matrices depend on interactions between anionic glycosaminoglycans. Elsevier; 2001; 49: 284-289. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/11428163
  101. Srinivasan SR, Xu J-H, Vijayagopal P, Radhakrishnamurthy B, Berenson GS. Low-density lipoprotein binding affinity of arterial chondroitin sulfate proteoglycan modulates cholesteryl ester accumulation in macrophages. Atherosclerosis. 1994; 109: 97.
  102. Hurt-Camejo E, Olsson U, Wiklund O, Bondjers G, Camejo G. Cellular Consequences of the Association of ApoB Lipoproteins With Proteoglycans. Arterioscler Thromb Vasc Biol. 1997; 17: 1011–1017. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/9194748
  103. Camejo G, Olofsson SO, Lopez F, Carlsson P, Bondjers G. Identification of Apo B-100 segments mediating the interaction of low density lipoproteins with arterial proteoglycans. Arterioscler Thromb Vasc Biol. 1988; 8: 368–377. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/3395272
  104. Skålén K, Gustafsson M, Rydberg EK, Hultén LM, Wiklund O, et al. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature. 2002; 417: 750–754. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/12066187
  105. Borén J, Olin K, Lee I, Chait A, Wight TN, et al. Identification of the principal proteoglycan-binding site in LDL. A single-point mutation in apo-B100 severely affects proteoglycan interaction without affecting LDL receptor binding. J Clin Invest. 1998; 101: 2658–2664. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/9637699
  106. Imberty A, Lortat-Jacob H, Pérez S. Structural view of glycosaminoglycan–protein interactions. Carbohydr Res. 2007; 342: 430–439. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/17229412
  107. Busch C, Dawes J, Pepper DS, Wasteson A. Binding of platelet factor 4 to cultured human umbilical vein endothelial cells. Thromb Res. 1980; 19: 129–137. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/7444850
  108. Stuckey JA, Charles RSt, Edwards BFP. A model of the platelet factor 4 complex with heparin. Proteins Struct Funct Bioinforma. 1992 ; 14: 277–287.
  109. Perollet C, Han ZC, Savona C, Caen JP, Bikfalvi A. Platelet Factor 4 Modulates Fibroblast Growth Factor 2 (FGF-2) Activity and Inhibits FGF-2 Dimerization. Blood. 1998; 91: 3289–3299. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/9558385
  110. Petersen F, Brandt E, Lindahl U, Spillmann D. Characterization of a Neutrophil Cell Surface Glycosaminoglycan That Mediates Binding of Platelet Factor 4. J Biol Chem. 1999; 274: 12376–12382. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/10212210
  111. Jin L, Abrahams JP, Skinner R, Petitou M, Pike RN, Carrell RW. The anticoagulant activation of antithrombin by heparin. Proc Natl Acad Sci. 1997; 94: 14683–14688. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/9405673
  112. Li W, Johnson DJD, Esmon CT, Huntington JA. Structure of the antithrombin–thrombin–heparin ternary complex reveals the antithrombotic mechanism of heparin. Nat Struct Mol Biol. 2004; 11: 857–862. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/15311269
  113. Raman R, Venkataraman G, Ernst S, Sasisekharan V, Sasisekharan R. Structural specificity of heparin binding in the fibroblast growth factor family of proteins. Proc Natl Acad Sci. 2003; 100:2357–2362. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/12604799
  114. Guerrini M, Agulles T, Bisio A, Hricovini M, Lay L, et al. Minimal Heparin/Heparan Sulfate Sequences for Binding to Fibroblast Growth Factor-1. Biochem Biophys Res Commun. 2002; 292: 222–230. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/11890696
  115. Capila I, Linhardt RJ. Heparin–Protein Interactions. Angew Chem Int Ed. 2002; 41: 390–412. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/12491369
  116. Desai UR, Petitou M, Björk I, Olson ST. Mechanism of Heparin Activation of Antithrombin Role of Individual Residues of the Pentasaccharide Activating Sequence in the Recognition of Native and Activated States of Antithrombin. J Biol Chem. 1998; 273: 7478–87. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/9516447
  117. Maimone MM, Tollefsen DM. Structure of a dermatan sulfate hexasaccharide that binds to heparin cofactor II with high affinity. J Biol Chem. 1990; 265: 18263–18271. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/2211700
  118. Liaw PCY, Becker DL, Stafford AR, Fredenburgh JC, Weitz JI. Molecular Basis for the Susceptibility of Fibrin-bound Thrombin to Inactivation by Heparin Cofactor II in the Presence of Dermatan Sulfate but Not Heparin. J Biol Chem. 2001; 276: 20959–20965. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/11294849
  119. Uca YO, Hallmann D, Hesse B, Seim C, Stolzenburg N, Pietsch H, et al. Microdistribution of Magnetic Resonance Imaging Contrast Agents in Atherosclerotic Plaques Determined by LA-ICP-MS and SR‑µXRF Imaging. Invest Radiol. 2020 Mar 24 (Manuscript submitted for publication)
  120. Collingwood JF, Adams F. Chemical imaging analysis of the brain with X-ray methods. Spectrochim Acta Part B At Spectrosc. 2017; 130: 101–18.
  121. Hare D, Austin C, Doble P. Quantification strategies for elemental imaging of biological samples using laser ablation-inductively coupled plasma- mass spectrometry. Analyst. 2012; 137: 1527–1537. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/22314636
  122. Kubaski F, Osago H, Mason RW, Yamaguchi S, Kobayashi H, et al. Glycosaminoglycans detection methods: Applications of mass spectrometry. Mol Genet Metab. 2017; 120: 67–77. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/27746032
  123. Caravan P. Strategies for increasing the sensitivity of gadolinium based MRI contrast agents. Chem Soc Rev. 2006; 35: 512-523. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/16729145
  124. Ziegler A, Seelig J. Binding and Clustering of Glycosaminoglycans: A Common Property of Mono- and Multivalent Cell-Penetrating Compounds. Biophys J. 2008; 94: 2142–2149. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/18065465
  125. Parish CR. The role of heparan sulphate in inflammation. Nat Rev Immunol. 2006; 6: 633–643. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/16917509
  126. Li Q, Park PW, Wilson CL, Parks WC. Matrilysin Shedding of Syndecan-1 Regulates Chemokine Mobilization and Transepithelial Efflux of Neutrophils in Acute Lung Injury. Cell. 2002; 111: 635–646. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/12464176
  127. Bernfield M, Götte M, Park PW, Reizes O, Fitzgerald ML, et al. Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem. 1999; 68: 729–777. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/10872465
  128. Handel TM, Johnson Z, Crown SE, Lau EK, Proudfoot AE. Regulation of Protein Function by Glycosaminoglycans—as Exemplified by Chemokines. Annu Rev Biochem. 2005; 74: 385–410. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/15952892
  129. Fischer JW, Steitz SA, Johnson PY, Burke A, Kolodgie F, et al. Decorin Promotes Aortic Smooth Muscle Cell Calcification and Colocalizes to Calcified Regions in Human Atherosclerotic Lesions. Arterioscler Thromb Vasc Biol. 2004; 24: 2391–2396. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/15472131
  130. McDonald JA. Extracellular matrix assembly. Annu Rev Cell Biol. 1988;4(1):183–207.
  131. Costa DS da, Reis RL, Pashkuleva I. Sulfation of Glycosaminoglycans and Its Implications in Human Health and Disorders. Annu Rev Biomed Eng. 2017; 19: 1–26. PubMed: https://www.ncbi.nlm.Fnih.gov/pubmed/28226217
  132. Thacker BE, Xu D, Lawrence R, Esko JD. Heparan sulfate 3-O-sulfation: A rare modification in search of a function. Matrix Biol. 2014; 35: 60–72. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/24361527
  133. Busby TF, Argraves WS, Brew SA, Pechik I, Gilliland GL, et al. Heparin Binding by Fibronectin Module III-13 Involves Six Discontinuous Basic Residues Brought Together to Form a Cationic Cradle. J Biol Chem. 1995; 270: 18558–18562. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/7629186

Figures:

Figure 1

Figure 1

Figure 1

Figure 2

Figure 1

Figure 3

Figure 1

Figure 4

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More

Contact

Editorial Office Emails:

info@hspioa.org

amelia.sandra@hspioa.us

elena.maya@hspioa.us

Select by Volume & Issue

Submit Manuscript Information for Authors Advisory Board Rss Feed Articles Rss Feed

Most Viewed Keywords

University/Institution

Select and search by University/Institution.

Articles by Country

Select and search by country to get related articles.

Testmonials

I would like to thank JPRA for taking this decision. I understand the effort it represents for you. I'm truly happy to have the paper published in JPRA. And I'll certainly consider JPRA for my next publications as I was satisfied of the service provided, the efficiency and promptness of the interactions we had.

Emmanuel BUSATO

Publishing with the International Journal of Clinical and Experimental Ophthalmology was a rewarding experience as review process was thorough and brisk. Their visibility online is second to none as their published articles appear in all search engines. I will encourage researchers to publish with them.

Elizabeth Awoyesuku

“The choice to submit the forensic case study to the Journal of Addiction Therapy and Research was dictated by the match between the content and the potential readership. The publication process proved to be expedient and we were provided with constructive feedback from reviewers. The final article layout is attractive and conforms to standards. All-in-all, it has been a rewarding process.”

Elisabeth H Wiig

Archives of Vascular Medicine is one of the top class journal for vascular medicine with highly interesting topics. You did a professional and great Job!

Elias Noory

Thank you very much. I think the review process and all of what concerns the administration of the publication concerning our paper has been excellent. The nice and quick answers have been very good I think.

Doris Nilsson

Journal of Pulmonary and Respiratory Research is good journal for respiratory research purposes. It takes 2-3 weeks maximum for review of the manuscript to get published and any corrections to be made in the manuscript. It needs good articles and studies to get publish in the respiratory medicine. I am really glad that this journal editors helped me to get my case report published.

Divya Khanduja

Thanks you and your colleague for the great help for our publication. You always provide prompt responses and high quality of service. I am so happy to have you working with me. Thanks again!

Diana (Ding) Dai

Service and process were excellent as was the “look” of the article when published.

Deane Waldman

Great, thank you! It was very efficient working w/ your group. Very thorough reviews (i.e., plagiarism, peer, etc.). Would certainly recommend that future authors consider working w/ your group.

David W Brett

Your services are very good

Chukwuka Ireju Onyinye

I very much appreciate the humanitarian services provided in my stead by this journal/publisher. It exhibits total absence of editorial impertinence. As an Author, I have been guided to have a fruitful experience. The editorial care is highly commendable.

Chrysanthus Chukwuma

"An amazing experience with the Journal of Advanced Pediatrics and Child Health. Very fast blind review with pertinent corrections and suggestions. I highly recommand both the journal and the editor."

Chaimae Khairoun

The submission is very easy and the time from submission to response from the reviewers is short. Correspondence with the journal is nice and rapid.

Catrin Henriksson

The Clinical Journal of Obstetrics and Gynecology is an open access journal focused on scientific knowledge publication with emphasis laid on the fields of Gynecology and Obstetrics. Their services toward us have been encouraging through their kindness and respect. Great consideration has been given to us as young budding researchers and we are very grateful for this.

Carole Assontsa

During the process your positive communication, prompt feedback and professional approach is very highly appreciated. We would like to thank you very much for your support.

Can Vuran

I do appreciate for your service including submission, analysis, review, editorial and publishing process. I believe these esteemed journal enlighten the science with its high-quality personel.

Bora Uysal

I am very much pleased with the fast track publication by your reputed journal's editorial team. It is really helpful for researchers like me from developing nations. I strongly recommend your journal for publication.

Badri Kumar Gupta

It has been a fabulous journey writing articles for your journal because of the encouragement you people provide for writers from developing nations like India. Kindly continue the same. Looking forward for a long term association.

Badareesh Lakshminarayana

Many thanks for publishing my article in your great journal and the friendly and hassle-free publication process, the constructive peer-review, the regular feedback system, and the Quick response to any queries.

Azab Elsayed Azab

I would like to thank this journal for publishing my Research Article. Something I really appreciate about this journal is, they did not take much time from the day of Submission to the publishing date. Looking forward to have more publications in future.

Ayush Chandra

Submission of paper was smooth, the review process was fast. I had excellent communication and on time response from the editor.

Ayokunle Dada

Your service is very good and fast reply, also your service understand our situation and support us to publication our articles.

Ayman M Abu Mustafa

Really good service with prompt response. Looking forward to having long lasting relationship with your journal

Avishek Bagchi

Your service is excellent. Processing and editing were very fast. I hope to publish more of my works in your journal.

Ausraful Islam

I wanna to thank Clinical Journal of Nursing Care and Practice for its effort to review and publish my manuscript. This is reputable journal. Thank you!

Atsedemariam Andualem

“It was a delightful experience publishing my manuscript with the Clinical Journal of Obstetrics and Gynecology. They offered me lots of opportunities I never had from most publishing houses and their prompt services are greatly appreciated.”

Asafo Jones

I hope to ability to make some new investigation and publish in Your Company in future.

Artur Stopyra

I like the quality of the print & overall service. The paper looks quite impressive. Hope this will attract interested readers. All of you have our best wishes for continued success.

Arshad Khan

Your big support from researchers around the world is the best appreciation from your scientific teams. We believe that there should be no barrier in science and you make it real and this motto come true.

Arefhosseinir Rafi

Your journal co-operation is very appreciable and motivational. I am really thankful to your journal and team members for the motivation and collaboration to publish my work.

Assistant Professor, UCLAS Uttaranchal University, Dehradun, India

Archna Dhasmana

I am glad to submit the article to Heighten Science Publications as it has a very smooth and fast peer-review process, which enables the researchers to communicate their work on time.

Anupam M

This is to specify that I have had an extensive and detailed interaction with the Editorial team of Annals of Clinical Gastroenterology and Hepatology, USA, lasting over a significant period of time. My interaction has been extremely pleasant, especially with Ms Allie Smith, as I find the communication quite inspiring and crystal clear. The attitude of aforesaid individuals is quite helpful and guiding in pertinent instances. It has been a commemorative journey so far working with the Journal and I hope that the symbiosis will continue, evolve and flourish in the forthcoming years. I wish the journal, related personnel and aforementioned individuals a fruitful, successful run.

New Delhi, India

Anubha Bajaj

We appreciate the fact that you decided to give us full waiver for the applicable charges and approve the final version. You did an excellent job preparing the PDF version. Of course we will consider your magazine for our future submissions and we will pay the applicable fees then.

Anna Dionysopoulou

''Co-operation of Archives of Surgery and Clinical Research journal is appreciable. I'm impressed at the promptness of the publishing staff and the professionalism displayed. Thank you very much for your support, help and encouragement.''

Anıl Gokce

Congratulations for the excellence of your journal and high quality of its publications.

Angel MARTIN CASTELLANOS

The service from the journal staff has been excellent.

Andy Smith

I was very pleased with the quick editorial process. We are sure that our paper will have great visibility, among other things due to its open access. We believe in science accessible to all.

Anderson Fernando de Souza

It was a great experience publishing through JCICM. The article has reached out to several institutions. Appreciate your professional work. Hope to work with you again

Anas Wardeh

Publishing an article is a long process, but working with your publication department made things go smoothly, even though the process took exactly 5 months from the time of submitting the article till the time I have favourable response, the missing part is the peer review details, which is essential in self auditing and future improvement, overall experience was excellent giving your understanding of the situation of lack of financial institution support.

Anas Diab

I think that Heighpubs very good. You are very helpful. Thank you for everything.

Ana Ribeiro

Regarding to be services, we note that are work with high standards of professionalism translated into quick response, efficiency which makes communication accessible. Furthermore, I believe to be much inviting for the submission of future works for publication purposes.

Amélia João Alice Nkutxi

I would like to mention that I had a wonderful experience working with HSPI. The whole process right from manuscript submission to peer review till the publication of the article was very prompt & efficient. I wish you good luck for the future.

Amarjeet Gambhir

Once I submitted the manuscript, the response time of the reviewers was very fast. The fine-tuning of the galley proof was likewise prompt. I believe the journal provide a valuable outlet to disseminate physical rehabilitation scientific knowledge to the clinical community. Respectfully. Dr. Alon

Alon

We really appreciate and thanks the full waiver you provide for our article. We happy to publish our paper in your journal. Thank you very much for your good support and services.

Ali Abusafia

It was a real pleasure working with your team. The review was done fast, and it was very clear, the editing was flawless, the article was published quickly compared to other journals, and everyone was understanding and helpful. I will gladly recommend this journal to my acquaintances in academia.

Alexandra Cozma

To the editorial team at HSPI and the Journal of Clinical Nephrology: Thank you so much for your hard work and collaboration in bringing our article to life. Your staff was responsive, flexible, and communicative and made the process smooth and easy. Thank you!

Alejandro Munoz

Dear colleagues! I am satisfied with our cooperation with you. Your service is at a high level. I hope for a future relationship. Let me know if I can get a paper version of the magazine with my articles from you. I see them on the Internet.

Aksenov V.V

"This is my first time publishing with the journal/publisher. I am impressed at the promptness of the publishing staff and the professionalism displayed. Thank you for encouraging young researchers like me!"

Ajite Kayode

I want to thank you for our collaboration. You were fast and effective with a positive spirit of teamwork. I am truly excited from our collaboration. You were like always fast, efficient and accurate. I hope that in the near future we will collaborate again.

Aikaterini Solomou

In my opinion, you provide a very fast and practical service.

Ahmet Eroglu

Great, We are too comfortable with the process including the peer review process and quality. But, the journal should be indexed in different databases such scopus.

Afework Edmealem

We really appreciate your efforts towards our article, the professional way you handle our request for exemption from charges. It was a great honor for us to publish in your magazine.

Achraf elbakkaly

I really liked the ease of submitting my manuscript in the HSPI journal. Further, the peer review was timely completed and I was communicated the final decision on my manuscript within 10 days of submission which is really appreciable. I strongly recommend all the scientists and researchers to submit their work in this journal”

Abu Bashar

My candid opinion is that the service you render is second to none. My favourite part is the prompt response to issue, really i value that.

Abiodun Akanbi Adeogun

Thank you very much for accepting our manuscript in your journal “International Journal of Clinical Virology”. We are very thankful to the esteemed team for timely response and quick review process. The editorial team of International Journal of Clinical Virology is too cooperative and well-mannered during the publication process. We are hopeful to publish many quality papers in your journal and I suggest the International Journal of Clinical Virology to all of my colleagues, researchers and friends to publish their research here.

Abdul Baset

I, Muhammad Sarwar Khan, am serving as Editor on Archives of Biotechnology and Biomedicine (ABB). I submitted an editorial titled, 'Edible vaccines to combat Infectious Bursal Disease of poultry' for publication in ABB. After submitting the manuscript; the services rendered by the management and technical personnel to handle and process the manuscript were marvelous. Plagiarism report was shared with me with complements before reviewers' comments, All steps including article processing and service charges were well taken care of keeping in view the author's interest/preference. All together, it was an encouraging and wonderful experience working with ABB personnel.

University of Agriculture, Pakistan

Muhammad Sarwar Khan

Your journal has accomplished its intended mission of providing very effective and efficient goals in dealing with submissions, conducting the reviewing process and in publishing accepted manuscripts in a timely manner. Keep up the great work and services that you provide.

University of Jacqmar, Inc., USA

John St. Cyr

I am to express my view that Heighten Science Publications are reliable quick even after peer review process. I hope and wish the publications will go a long way in disseminating science to many interested in scientific research.

College of Fisheries, CAU(I), Tripura, India

Ajit Kumar Roy

The Journal Clinical Nephrology provides a good opportunity for readers to stay updated in the field of clinical nephrology. Additionally - it provides a good opportunity for authors to publish their work. 1. Publication of the accepted manuscripts is sufficiently rapid. 2. The trust factor between the journal and me, as an author, is very important and well preserved. 3. Peer review process very rapid and effective.

Assaf Harofeh Medical Center, Israel

Leonid Feldman

In 2017, I submitted a manuscript to the journal Archives of Biotechnology and Biomedicine belonging to Heighten Science Publications Corporation. Within one week I already received the response from the editor. All processing steps were really fast so in terms of a speedy publication I can particularly recommend the journal Archives of Biotechnology and Biomedicine. The responsible contact person of the journal was always available, which gives a trustworthy impression to the author. Also the peer review process was clear and constructive. So from my experience with Heighten Science Publications Corporation I can recommend publishing there.

University of Tubingen, Germany

Yvonne Mast

We thank to the heighten science family, who speed up the publication of our article and provide every support.

Mehmet Besir

The services of the journal were excellent. The most important thing for an author is the speed of the peer review which was really fast here. They returned in a few days and immediately replied all of my questions. I want to refer this platform to all scholars. Many thanks.

Eastern Mediterranean University, Cyprus

Zehra Guchan TOPCU

Thank you for your attitude and support. I am sincerely grateful to you and the entire staff of the magazine for the high professionalism and fast quality work. Thank you very much!

USA

Igor Klepikov

Thank you and your company for effective support of authors which are very much dependable on the funds gambling for science in the different countries of our huge and unpredictable world. We are doing our work and should rely on a teams like Galley Proof-HSPC. Great success to all of you for the 2019th! Be well all the year long.

Russia

Victor V Apollonov

The editorial process was quickly done. The galley proof was sent within a week after being accepted for publication. The editorial team was very helpful and responded promptly.

India

Rohit Kulshrestha

Publishing with the International Journal of Clinical and Experimental Ophthalmology was a rewarding experience as review process was thorough and brisk. Their visibility online is second to none as their published articles appear in all search engines. I will encourage researchers to publish with them.

University of Port Harcourt Teaching Hospital, Nigeria

Dr. Elizabeth A Awoyesuku

"It was a pleasure to work with the editorial team of the journal on the submission of the manuscript. The team was professional, fast, and to the point".

NC A&T State University, USA

Moran Sciamama-Saghiv

Submission of paper was smooth, the review process was fast. I had excellent communication and on time response from the editor.

Ekiti State University Teaching Hospital, Nigeria

Ayokunle Dada

I am delighted and satisfied with. Heighten Science Publications as my manuscript was thoroughly assessed and published on time without delay. Keep up the good work.

Ido-Ekiti/Afe Babalola University, Nigeria

Dr. Shuaib Kayode Aremu

"This is my first time publishing with the journal/publisher. I am impressed at the promptness of the publishing staff and the professionalism displayed. Thank you for encouraging young researchers like me!"

Ekiti State University, Nigeria

Adebukola Ajite

I wanna to thank clinical journal of nursing care and practice for its effort to review and publish my manuscript. This is reputable journal. Thank you!

Wollo University, Ethiopia

Atsedemariam Andualem

We appreciate your approach to scholars and will encourage you to collaborate with your organization, which includes interesting and different medical journals. With the best wishes of success, creativity and joy in life, prosperity in the medical field.

Ivano- Frankivsk National Medical University, Ukraine

Nataliya Kitsera

Thank you very much for your support and encouragement. I am truly impressed by your tolerance and support. Thank you very much

Diaverum: PADC, Jeddah, Saudi Arabia

Nasrulla Abutaleb

You are such a nice person. Your journal co-operation is very appreciable and motivational.

Department of Biotechnology, Uttaranchal college of Applied and Life Sciences, Uttaranchal University, Dehradun, Uttarakhand, India

Archna Dhasmana

“Mobile apps and wearable technology are becoming ubiquitous in our environment. Their integration with healthcare delivery is just beginning to take shape. The early results are promising and the possibilities great."

BS, PharmD., MBA, CPHIMS, FHIMSS, Adjunct Professor, Global Healthcare Management, MCPHS University, Chief Strategy Offi cer, MedicaSoft, Senior Advisor, National Health IT (NHIT) Collaborative for Underserved, New York HIMSS, National Liaison, Health 2.0 Boston, Past Chair, Chair Innovation, USA

Helen Figge

“The choice to submit the forensic case study to the Journal of Addiction Therapy and Research was dictated by the match between the content and the potential readership. The publication process proved to be expedient and we were provided with constructive feedback from reviewers. The final article layout is attractive and conforms to standards. All-in-all, it has been a rewarding process.”

Ph.D, Boston University Department of Communication Sciences and Disorders and Knowledge Research Institute, Inc., 2131 Reflection Bay Drive, Arlington, Texas 76013, USA

Elisabeth H. Wiig

The service is nice and the time of processing the application is fast.

Department of Neurosurgery, Queen Elizabeth Hospital, Hong Kong

Long Ching

Your service is very good and fast reply, Also your service understand our situation and support us to publication our articles.

Palestine College of Nursing, Khan Younis, Gaza Strip, Palestine

Ayman M Abu Mustafa

“It was a delightful experience publishing my manuscript with the Clinical Journal of Obstetrics and Gynecology. They offered me lots of opportunities I never had from most publishing houses and their prompt services are greatly appreciated.”

Department of Agricultural Economics, Agribusiness and Extension, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana

Akowuah Jones Asafo

View More

Related Journals

Help ?